| Identification | Back Directory | [Name]
3H-1,2,4-Triazol-3-one, 5-[2,4-dihydroxy-5-(1-methylethyl)phenyl]-2,4-dihydro-4-[1-[2-(4-piperidinyl)ethyl]-1H-indol-5-yl]- | [CAS]
1472616-61-7 | [Synonyms]
3H-1,2,4-Triazol-3-one, 5-[2,4-dihydroxy-5-(1-methylethyl)phenyl]-2,4-dihydro-4-[1-[2-(4-piperidinyl)ethyl]-1H-indol-5-yl]- | [Molecular Formula]
C26H31N5O3 | [MOL File]
1472616-61-7.mol | [Molecular Weight]
461.56 |
| Hazard Information | Back Directory | [Uses]
DP-1, a degradation product of SDC-TRAP-0063, is a fragment of Ganetespib. Ganetespib is a heat shock protein 90 (HSP90) inhibitor with anti-tumor activity[1]. | [Biological Activity]
DP-1, a degradation product of SDC-TRAP-0063, is a fragment of Ganetespib. Ganetespib is a heat shock protein 90 (HSP90) inhibitor with anti-tumor activity[1].
DP-1 is the SDC-TRAP-0063 degradation product which can be found in plasma, tumor and heart[1]. | [in vivo]
DP-1 is the SDC-TRAP-0063 degradation product which can be found in plasma, tumor and heart[1]. | [storage]
Store at -20°C | [References]
[1]. Chimmanamada DU, et, al. Targeted therapeutics. US20140079636A1. |
|
|